Haemonetics Corp (HAE)
95.90
+3.30
(+3.56%)
USD |
NYSE |
May 10, 16:00
95.90
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Enterprise Value: 5.379B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 5.379B |
| May 08, 2024 | 5.412B |
| May 07, 2024 | 5.511B |
| May 06, 2024 | 5.521B |
| May 03, 2024 | 5.471B |
| May 02, 2024 | 5.416B |
| May 01, 2024 | 5.356B |
| April 30, 2024 | 5.346B |
| April 29, 2024 | 5.324B |
| April 26, 2024 | 5.298B |
| April 25, 2024 | 5.129B |
| April 24, 2024 | 5.055B |
| April 23, 2024 | 4.997B |
| April 22, 2024 | 4.923B |
| April 19, 2024 | 4.802B |
| April 18, 2024 | 4.915B |
| April 17, 2024 | 4.987B |
| April 16, 2024 | 4.951B |
| April 15, 2024 | 4.987B |
| April 12, 2024 | 5.005B |
| April 11, 2024 | 5.071B |
| April 10, 2024 | 5.052B |
| April 09, 2024 | 5.098B |
| April 08, 2024 | 5.010B |
| April 05, 2024 | 4.976B |
| Date | Value |
|---|---|
| April 04, 2024 | 4.988B |
| April 03, 2024 | 4.939B |
| April 02, 2024 | 4.951B |
| April 01, 2024 | 4.983B |
| March 28, 2024 | 5.011B |
| March 27, 2024 | 4.947B |
| March 26, 2024 | 4.823B |
| March 25, 2024 | 4.832B |
| March 22, 2024 | 4.754B |
| March 21, 2024 | 4.754B |
| March 20, 2024 | 4.730B |
| March 19, 2024 | 4.613B |
| March 18, 2024 | 4.526B |
| March 15, 2024 | 4.476B |
| March 14, 2024 | 4.516B |
| March 13, 2024 | 4.554B |
| March 12, 2024 | 4.581B |
| March 11, 2024 | 4.656B |
| March 08, 2024 | 4.720B |
| March 07, 2024 | 4.625B |
| March 06, 2024 | 4.610B |
| March 05, 2024 | 4.562B |
| March 04, 2024 | 4.474B |
| March 01, 2024 | 4.443B |
| February 29, 2024 | 4.383B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.777B
Minimum
Jan 27 2022
7.278B
Maximum
Aug 16 2019
4.877B
Average
4.781B
Median
Enterprise Value Benchmarks
| Stryker Corp | 136.50B |
| ResMed Inc | 32.62B |
| Masimo Corp | 7.315B |
| Insulet Corp | 13.13B |
| InfuSystems Holdings Inc | 189.63M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 31.24M |
| Revenue (Quarterly) | 336.25M |
| Total Expenses (Quarterly) | 290.27M |
| EPS Diluted (Quarterly) | 0.61 |
| Gross Profit Margin (Quarterly) | 52.90% |
| Profit Margin (Quarterly) | 9.29% |
| Earnings Yield | 2.57% |
| Operating Earnings Yield | 3.66% |
| Normalized Earnings Yield | 2.719 |